Skip to main content

Abstract

Obesity is becoming one of the major health problems across the world [1]. The risks involved with being overweight or obese are related to the deposition of adipose tissue (adiposity) that is associated with increased risk of adverse health problems. Dosing medications in obese subjects is a challenge as these patients are often excluded from many premarketing clinical drug trials. Current dosage recommendations for most drugs for obese patients are most often inferred from normal-weight persons. As the pharmacokinetics (PK) and pharmacodynamics (PD) of many drugs are altered by the disproportional increase of adiposity relative to lean body mass in morbid obesity, dosing based on total body weight could lead to the risk of overdose and serious clinical complications. An individualised dosing scalar that takes into account the changed body composition should be used in MO patient, particularly in anaesthesia and intensive care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Bjorntorp P. Obesity. Lancet. 1997;350:423–6.

    Article  CAS  PubMed  Google Scholar 

  2. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32:959–66.

    Article  CAS  Google Scholar 

  3. Gallagher D, Visser M, Sepulveda D, et al. How useful is body mass index for comparison of body fatness across age, sex and ethnic groups? Am J Epidermiol. 1996;143:228–39.

    Article  CAS  Google Scholar 

  4. Taylor AE, Ebrahim S, Ben-Shlomo Y, et al. Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using date form 4 UK cohorts. Am J Clin Nutr. 2010;91:547–56.

    Article  CAS  PubMed  Google Scholar 

  5. Gelber RP, Gaziano JM, Orav EJ, et al. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol. 2008;52:605–15.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Duffull SB, Dooley MJ, Green B, et al. A standard weight descriptor for dose adjustments in the obese patient. Clin Pharmacokinet. 2004;43:1167–78.

    Article  PubMed  Google Scholar 

  7. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39:215–31.

    Article  CAS  PubMed  Google Scholar 

  8. Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118:1117–23.

    Article  CAS  PubMed  Google Scholar 

  9. Vasan KM, Lopez-Berestein G. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch Med Res. 1993;24:395–401.

    Google Scholar 

  10. Wada DR, Bjirkman S, Ebling WF, et al. Computer stimulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology. 1997;87:884–99.

    Article  CAS  PubMed  Google Scholar 

  11. Alvarez AO, Cascardo A, Albarracin Menendez S, et al. Total intravenous anesthesia with midazolam, remifentanil, propofol, cisatracurium in morbid obesity. Obes Surg. 2000;10:353–60.

    Article  CAS  PubMed  Google Scholar 

  12. Servin F, Farinotti R, Haberer JP, et al. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology. 1993;78:657–65.

    Article  CAS  PubMed  Google Scholar 

  13. Greenblatt DJ, Abernethy DR, Locniskar A, et al. Effect of age, gender and obesity on midazolam kinetics. Anesthesiology. 1984;61:27–35.

    Article  CAS  PubMed  Google Scholar 

  14. Juvin P, Vadam C, Malek DH, et al. Postoperative recovery after desflurane, propofol or isoflurane anesthesia among morbidly obese patients: a prospective randomized study. Anesth Analg. 2000;91:714–9.

    Article  CAS  PubMed  Google Scholar 

  15. Strum DP, Eger EI. Partition coefficients of desflurane in human blood saline and olive oil. Anesth Analg. 1987;66:971–3.

    Google Scholar 

  16. Arain SR, Barth CD, Shankar H, Ebert TJ. Choice of volatile anesthetic for the morbidly obese patient: sevoflurane or desflurane. J Clin Anesth. 2005;17:413–9.

    Article  CAS  PubMed  Google Scholar 

  17. Lemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg. 2006;102:438–42.

    Article  CAS  PubMed  Google Scholar 

  18. Leykin Y, Pellis T, Lucca M, et al. The pharmacodynamics effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg. 2004;99:1086–9.

    Article  PubMed  Google Scholar 

  19. Leykin Y, Pellis T, Lucca M, et al. The effects of cisatracurium on morbidly obese women. Anesth Analg. 2004;99:1090–4.

    Article  CAS  PubMed  Google Scholar 

  20. Loupec T, Frasca D, Rousseau N, et al. Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients. Anaesthesia. 2016;71(3):265–72.

    Article  CAS  PubMed  Google Scholar 

  21. Casati A, Putuz M. Anesthesia in the obese patient: pharmacokinetic considerations. J Clin Anesth. 2005;17:134–45.

    Article  CAS  PubMed  Google Scholar 

  22. Macintyre PE, Jarvis DA. Age is the best predictor of postoperative morphine requirements. Pain. 1996;64:357–64.

    Article  CAS  PubMed  Google Scholar 

  23. Lotsch J, Dudziak R, Freynhagen R, et al. Fatal respiratory depression after multiple intravenous morphine injections. Clin Pharmacokinet. 2006;45:1051–60.

    Article  PubMed  Google Scholar 

  24. Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists task force on perioperative management of patients with obstructive sleep apnea. Anesthesiology. 2006;104:1081–93.

    Article  PubMed  Google Scholar 

  25. Kehlet H, Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anesth. 2001;87:62–72.

    Article  CAS  Google Scholar 

  26. Von Ungern-Sternberg BS, Regli A, Reber A, Schneider MC. Effect of obesity and thoracic epidural analgesia on perioperative spirometry. Br J Anaesth. 2005;94:121–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clement Lee .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Lee, C., Millington, K., Manuel, A. (2018). Drugs and Medications. In: Esquinas, A., Lemyze, M. (eds) Mechanical Ventilation in the Critically Ill Obese Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-49253-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49253-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49252-0

  • Online ISBN: 978-3-319-49253-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics